drugset / Trial / NCT01159808

A Study of the Safety and Pharmacokinetics of Single Ascending Oral Doses of INX-08189 in Healthy Subjects

NCT01159808

Phase 1 Completed 42 enrolled Bristol-Myers Squibb
RandomizedFactorialTriple-blind

Summary

The purpose of this study is to test the safety of different dose strengths of INX-08189 in healthy adults. The study will also look at how rapidly the drug breaks down in the body (pharmacokinetics or PK). The study objectives include: * To evaluate the safety of single ascending oral doses of INX-08189 in healthy subjects * To characterize the pharmacokinetic (PK) profile of single ascending oral doses of INX-08189 in healthy subjects * To assess the food effect on the PK of a single oral dose of INX-08189

Timeline

Start
2010-05
Primary completion
2010-08
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-986094 Small molecule 3 mg Oral
Subject BMS-986094 Small molecule 25 mg Oral
Subject BMS-986094 Small molecule 100 mg Oral

Indications

No indication recorded.